Learning impairment produced in rats by the cannabinoid agonist HU 210 in a water-maze task

Pharmacology Biochemistry and Behavior

Volumn 64, Issue 3, 1999, Pages 555-561

  Ferrari, F ^a   Ottani, A ^a   Vivoli, R ^b   Giuliani, D ^a  

^a Institute of Pharmacology   (Italy)

^b Microbiological Biostatistical S ^*  (Italy)

Author keywords

Cannabinoids; HU 210; Morris water maze; Motor activity; Rat; Spatial learning; Vocalization

Indexed keywords

CANNABINOID; DEXANABINOL;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; INTRAPERITONEAL DRUG ADMINISTRATION; LEARNING; LEARNING DISORDER; MALE; MOTOR ACTIVITY; MOTOR PERFORMANCE; NONHUMAN; PRIORITY JOURNAL; RAT; SPATIAL MEMORY; TASK PERFORMANCE; VOCALIZATION;

ANIMALS; CANNABINOIDS; CUES; DEPRESSION, CHEMICAL; FORELIMB; MALE; MAZE LEARNING; NEUROPROTECTIVE AGENTS; PSYCHOMOTOR PERFORMANCE; PYRAMIDAL TRACTS; RATS; RATS, WISTAR; TETRAHYDROCANNABINOL;

ANIMALIA;

EID: 0032832155     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(99)00106-9     Document Type: Article

References (42)

1. Abel E.L. Marihuana and memory. Nature. 227:1970;1151-1152.
2. Arbel I., Kadar T., Silbermann M., Levy A. The effects of long-term corticosterone administration on hippocampal morphology and cognitive performance of middle-aged rats. Brain Res. 657:1994;227-235.
3. Barnes C.A. Spatial learning and memory processes. The search for their neurobiological mechanisms in the rats Trends Neurosci. 11:1988;163-169.
4. Bjorklund A., Dunnett S.B., Stenevi U., Lewis M.E., Iversen S.D. Reinnervation of the denervated striatum by substantia nigra transplants. Functional consequence as revealed by pharmacological and sensorimotor testing Brain Res. 199:1980;307-333.
5. Bodnoff S.R., Humphreys A.G., Lehman J.C., Diamond D.M., Rose G.M., Meaney M.J. Enduring effects of chronic corticosterone treatment on spatial learning, synaptic plasticity, and hippocampal neuropathology in young and mid-aged rats. J. Neurosci. 15:1995;61-69.
6. Compton D.R., Johnson M.R., Melvin L.S., Martin B. Pharmacological profile of a series of bicyclic cannabinoid analogs. Classification as cannabimimetic agents J. Pharmacol. Exp. Ther. 260:1992;201-209.
7. 37]CRF attenuates the acute action of the highly potent cannabinoid receptor agonist HU 210 on defensive-withdrawal behavior in rats. J. Pharmacol. Exp.Ther. 276:1996;56-64.
8. Devane W.A., Dysarz F.A. III, Johnson M.R., Melvin L.S., Howlett A.C. Determination and characterization of a cannabinoid receptor in rat brain. Mol. Pharmacol. 34:1988;605-613.
9. Dewey W.L., Peng T.C., Harris L.S. The effect of 1-trans-delta 9THC on the hypothalamo-hypophyseal-adrenal axis of rats. Eur. J. Pharmacol. 12:1970;382-384.
10. Dunn A.J., File S.E. Corticotropin-releasing factor has an anxiogenic action on the social interaction test. Horm. Behav. 21:1987;193-202.
11. Ferrari F., Ottani A., Giuliani D. Cannabinoid activity in rats and pigeons of HU 210, a potent anti-emetic drug. Pharmacol. Biochem. Behav. 62:1999;75-80.
12. Fishman M.V., Rosenbaum J.F., Yabusaki D.I., Carr D.B. Marijuana related anxiety. A questionnaire based pilot sudy of normal and psychiatric populations Res. Commun. Subst. Abuse. 9:1988;219-226.
13. Fride E., Mechoulam R. Pharmacological activity of the cannabinoid receptor agonist, anandamide, a brain constituent. Eur. J. Pharmacol. 231:1993;313-314.
14. Gaoni Y., Mechoulam R. Isolation, structure and partial synthesis of an active constituent of hashish. J. Am. Chem. Soc. 86:1964;1646-1647.
15. Gessa G.L., Casu M.A., Carta G., Mascia M.S. Cannabinoids decrease acetylcholine release in the medial-prefrontal cortex and hyppocampus, reversal by SR 141716A. Eur. J. Pharmacol. 355:1998;119-124.
16. Gispen W.H., Wiegant H.M., Greven H.M., De Wied D. The induction of the excessive grooming in the rat by intraventricular application of peptides derived from ACTH-structure activity studies. Life Sci. 17:1975;645-650.
17. Henriksson B.G., Jarbe T.U.C. Cannabisinduced vocalization in the rat. J. Pharm. Pharmacol. 23:1971;456-458.
18. Herkenham M., Lynn A.B., Johnson M.R., Melvin L.S., De Costa B.R., Rice K.C. Characterization and localisation of cannabinoid receptors in rat brain. A quantitative in vitro autoradiographic study J. Neurosci. 11:1991;563-583.
19. Heyser C.J., Hampson R.E., Deadwyler S.A. Effects of delta-9-THC on delayed match to sample performance in rats. Alterations in short-term memory associated with changes in task specific firing of hippocampal cells J. Pharmacol. Exp. Ther. 264:1993;294-307.
20. Howlett A.C., Champion T.M., Wilken G.H., Mechoulam R. Stereochemical effects of 11-OH-delta 8-tetrahydrocannabinol-dimethylheptyl to inhibit adenylate cyclase and bind to the cannabinoid receptor. Neuropharmacology. 29:1990;161-165.
21. Landfield, P. W.; Deadwyler, S. A., eds.: Long-term potentiation: From biophysics to behaviour. New York: Liss.
22. Lessin P.J., Thomas S.A. Assessment of the chronic effects of marihuana on motivation and achievement. a preliminary report Braude M.C., Szara S. Pharmacology of marihuana, vol. 2. 1976;681-684 Raven Press, New York.
23. Lichtman A.H., Dimen K.R., Martin B.R. Systemic or intrahippocampal cannabinoid administration impairs spatial memory in rats. Psychoparmacology (Berlin). 119:1995;655-662.
24. Lindamood C. III, Colasanti B.K. Effects od delta-9-THC and cannabidiol on Na+-dependent, high affinity choline uptake in the rat hippocampus. J. Pharmacol. Exp. Ther. 213:1980;216-221.
25. Little P.J., Compton D.R., Mechoulam R., Martin B.R. Stereochemical effects of 11-OH-(8-THC)-dimethyleptyl in mice and dogs. Pharmacol. Biochem. Behav. 32:1989;661-666.
26. Maclean K.I., Littleton J.M. Environmental stress as a factor in the response of rat brain catecholamine metabolism to delta 9 THC. Eur. J. Pharmacol. 4:1977;171-182.
27. Mailleux P., Verslijpe M., Vanderhaeghen J.J. Initial observation on the distribution of cannabinoid receptor binding sites in the human adult basal ganglia using autoradiography. Neurosci. Lett. 139:1992;7-9.
28. McNamara R.K., Skelton R.W. The neuropharmacological and neurochemical bases of place learning in the Morris water maze. Brain Res. Rev. 18:1993;33-49.
29. Meyer R.E. Behavioural pharmacology of marijuana. Lipton M.A., Di Mascio A., Killam K.F. Psychopharmacology. A generation of progress:1978;1639-1652 Raven Press, New York.
30. Miller L.L., Branconnier R.J. Cannabis. Effects on memory and the cholinergic limbic system Psychol. Bull. 93:1983;441-456.
31. Morris R.G.M., Garrud P., Rawlins J.N.P., O'Keefe J. Place navigation impaired in rats with hippocampal lesions. Nature. 297:1982;681-683.
32. Morrison B.J., Thatcher K. Overpopulation effects on social reduction of emotionality in the albino rat. J. Comp. Physiol. Psychol. 69:1969;658-662.
33. Nowicky A.V., Teyler T.J. The modulation of long-term potentiation by delta-9-tetrahydrocannabinol in the rat hippocampus, in vitro. Brain Res. Bull. 19:1987;663-672.
34. Ovadia H., Wohlman A., Mechoulam R., Weidenfeld J. Characterization of the hypothermic effect of the synthetic cannabinoid HU 210 in the rat. Relation to the adrenergic system and endogenous pyrogens. Neuropharmacology. 34:1995;175-180.
35. Romero J., Garcia L., Cebeira M., Zadrozny D., Fernandez-Ruiz J.J., Ramos J.A. The endogenous cannabinoid receptor ligand, anandamide, inhibits the motor behavior. Role of nigrostriatal dopaminergic neurons Life Sci. 56:1995;2033-2040.
36. Squire L.R. Memory and the hippocampus. A synthesis from findings with rats, monkeys and humans Psychol. Rev. 99:1992;195-231.
37. Sutherland R.J., Rudy J.W. Place learning in the Morris place navigation task is impaired by damage to the hippocampal formation even if the temporal demands are reduced. Psychobiology. 16:1988;157-163.
38. Teigen K.H. A law for all seasons. Yerkes-Dodson F.J. Theory and psychology, vol. 4. 1994;525-547 Springer Verlag, New York.
39. Terranova J.P., Michaud J.C., Le Fur G., Soubrie P. Inhibition of long-term potentiation in rat hippocampal slices by anandamide and WIN 55212-2. Reversal by SR141716A, a selective antagonist of CB1 cannabinoid receptors Naunyn Schmiedebergs Arch. Pharmacol. 352:1995;576-579.
40. Teyler T.J., DiScenna P. Long-term potentation. Annu. Rev. Neurosci. 10:1987;131-161.
41. Warren S.G., Juraska J. Spatial and nonspatial learning across the rat estrous cycle. Behav. Neurosci. 2:1997;259-266.
42. 9 THC in normal subjects. Psychopharmacology (Berlin). 76:1982;245-250.